Inhibition of TAK1/JNK/AP-1 and TAK1/IκB Kinase Pathways in RCC Cell Lines by NVP-BEZ235 and PP242 Rather Than Rapamycin. This evidence concerns the gene MAPK8 and renal cell carcinoma.